LEI: 213800DQGNQE3X76WS92
12 November 2024
BREEDON GROUP plc
(the Company)
Director / PDMR Dealings
The Company has been notified that, pursuant to a dividend reinvestment plan, on 12 November 2024 Clive Watson, Non-executive Director of Breedon Group plc and a Person Discharging Managerial Responsibilities (PDMR), bought 261 shares of
This notification is made in accordance with the requirements of Article 19 of the
Enquiries:
Breedon Group plc www.breedongroup.com
Susan Bolton, Deputy Company Secretary 01332 981215
Louise Turner-Smith, Head of Investor Relations 07860 911909
MHP (Public Relations Adviser) 020 3128 8613
Reg Hoare
Rachel Farrington
Charles Hirst
Notification and public disclosure of transactions by persons discharging managerial
responsibilities and persons closely associated with them
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
a) |
Name |
Clive Watson |
||||
2 |
Reason for the notification |
|||||
a) |
Position/status |
Non-executive Director and PDMR |
||||
b) |
Is this an initial notification or an amendment to a prior notification? |
Initial notification |
||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
a) |
Name |
Breedon Group plc |
||||
b) |
LEI |
213800DQGNQE3X76WS92 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of
GB00BM8NFJ84 |
||||
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information (if any)
- Aggregated volume
- Price |
261
|
||||
e) |
Date of transaction |
12 November 2024 |
||||
f) |
Place of the transaction |
London Stock Exchange plc |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.